Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Regenerative Biologics Institute (RBI) Offers Next Generation Regenerative Treatments Including Stem Cell Therapy and Platelet Rich Plasma (PRP)
  • USA - English


News provided by

Regenerative Biologics Institute

Feb 08, 2017, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Vero Beach, FL (PRWEB) February 08, 2017 -- The Regenerative Biologics Institute, or RBI, has opened a state-of-the-art facility in Vero Beach, FL to offer innovative regenerative therapies to patients on the Treasure Coast and throughout Florida. RBI is the first of its kind center of excellence in the area that specializes in minimally-invasive regenerative therapies and is complete with a dedicated biologics laboratory. RBI also utilizes advanced image guidance technology including ultrasound and even live x-ray for precise delivery of therapeutics into certain areas of the body like the spine. Regenerative Medicine is an innovative approach that utilizes a patient’s own natural regenerative ability in the form of stem cells and platelets to treat degenerative conditions, sports injuries and more. The field has been recognized worldwide as one that offers the potential to dramatically impact patient care in the 21st century.

Millions of Americans suffer from chronic pain or sustain injuries during their lives that can often be debilitating and limit their daily activities. RBI’s stem cell therapy and platelet rich plasma therapy (PRP), treatments may offer new hope to these patients since they are among the few therapies that offer the true promise of treating the underlying causes of degenerative conditions instead of just treating the symptoms. The ultimate goal of using regenerative therapies is reduce pain, rebuild healthier tissue and restore more normal tissue function allowing patients to live and age better.

“We are very excited about opening an RBI facility in Vero Beach,” said Jason Griffeth, RBI’s Managing Director. “I’ve had the opportunity to travel the globe learning, teaching and developing regenerative medicine techniques for nearly 15 years so it is exciting to bring this expertise to my home town. Our goal is to establish one of the premier regenerative medicine clinics in Florida and to help patients feel & function better using their own bodies natural healing ability.”

RBI treats a wide variety of conditions including back/spine pain, sports related injuries, arthritis and more. RBI’s therapies use the body’s natural healing capability to stimulate and enhance healing without side effects. All RBI’s treatments are non-surgical and minimally invasive so they require little down time post-procedure, allowing patients to get back to their active lifestyle quickly. The entire treatment can be completed within a couple hours and patients return home the very same day.

For stem cell therapy treatments, a small tissue sample is taken from a patient then processed to isolate and concentrate millions of regenerative cells. These cells are then combined with bioactive platelets and injected precisely into an area of need such as a degenerative disc or arthritic joint.

Platelet Rich Plasma, commonly known as PRP, is derived from a patient’s own blood sample and is composed of highly concentrated platelets and growth factors. PRP has been shown to stimulate healing in soft tissues by supplying growth factors, cytokines and other bioactive proteins. PRP can also act as a biological scaffold for stem cell treatments which can potentially enhance healing even further.

Once available only to professional athletes, RBI aims to bring these innovative therapies to all patients that can benefit from them. If you would like to talk to one of our experienced team members to see if you might benefit from RBI’s regenerative therapies, please call us at 772-492-6973, email us at info(at)rbistemcell(dot)com or visit our website at http://www.rbistemcell.com.

About RBI’s Team

RBI’s unique model is to combine experts and leading scientists from the regenerative medicine field with clinicians that are trained in precise injection techniques. Our Managing Director, Jason Griffeth, has been in the regenerative medicine field for nearly 15 years and has directed the science & development of a number of pioneering regenerative therapies worldwide. He was worked with clinicians at leading research institutions to develop some of the most advanced regenerative medicine treatment protocols and stem cell isolation protocols available.

RBI’s Medical Director, Dr. Brett Haake, is a Board Certified Anesthesiologist that has trained with leading stem cell scientists and clinicians. His fervent interest in the field of regenerative medicine is due to his lifelong participation in athletics and service in the military. He joined RBI in order to be on the cutting edge of immunomodulatory therapies including stem cell and PRP treatments. As a Specialist in Anesthesiology, Dr. Haake is a highly trained physician that draws on his extensive knowledge in physiology, pharmacology and diseases to guide his treatment techniques.

Jason Griffeth, Regenerative Biologics Institute, https://rbistemcell.com/, +1 9542607118, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.